968P Neoadjuvant nivolumab (N) plus weekly carboplatin (C) and paclitaxel (P) outcomes in HPV(-) resectable locally advanced head and neck cancer
Ralph Zinner, Jennifer M. Johnson, Madalina Tuluc, Joseph Curry, Adam Luginbuhl, Christopher Fundakowski, Andrew Yampolsky, Richard A. Goldman, Charalambos Solomides, Stacey K. Mardekian, C. Tuckey, Grace Lu‐Yao, Larry A. Harshyne, Dorit Arditti-Falk, Dawn Poller, Benjamin E. Leiby, Voichita Bar‐Ad, R. Axelrod, Athanassios Argiris, David M. Cognetti
Topics & Concepts
MedicineClinical endpointInternal medicineOncologyRegimenPrimary tumorCarboplatinNivolumabCancerStage (stratigraphy)SurgeryMetastasisChemotherapyClinical trialCisplatinImmunotherapyPaleontologyBiologyHead and Neck Cancer StudiesCancer Diagnosis and TreatmentCancer Immunotherapy and Biomarkers